FrancophonIA/ELRC3.0 huggingface dataset:
English: Treatment and metaphylaxis of Infectious Sinusitis and Airsacculitis caused by Mycoplasma gallisepticum, Mycoplasma synoviae and Mycoplasma meleagridis susceptible to tiamulin.
Maltese: Tiamulin hydrogen fumarate hu kkunsidrat li għandu indiċi terapewtiku adegwat fil-qżieqeż, u ma ġietx stabbilita doża letali minima.
English: The dosage is 25 mg tiamulin hydrogen fumarate (equivalent to 55.6 mg of product)/kg body weight administered daily for the period of 3 to 5 consecutive days.
Maltese: Id-dożaġġ hu ta'25 mg ta'tiamulin hydrogen fumarate (ekwivalenti għal 55.6 mg ta'prodott)/kg ta'piż tal-ġisem kuljum, mogħti għal perjodu ta'3 sa 5 ijiem.
English: Further information on Leucogen can be found on the Agency's website: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
Maltese: ema.europa.eu/Find medicine/Veterinary medicines/European public assessment reports.
English: Leucogen (feline leukaemia inactivated vaccine) EMA/121375/2009
Maltese: Leucogen (tilqima inattivata kontra l-lewkimja tal-qtates) EMA/121375/2009
English: Other information about Leucogen
Maltese: Informazzjoni oħra dwar Leucogen
English: Leucogen received a marketing authorisation valid throughout the EU for Leucogen on 17 June 2009.
Maltese: Leucogen ingħata awtorizzazzjoni għat-tqegħid fis-suq valida fl-UE kollha fis-17 ta' Ġunju 2009.
English: Leucogen (feline leukaemia inactivated vaccine)
Maltese: Leucogen (tilqima inattivata kontra l-lewkimja tal-qtates)
English: In a second study, kittens aged 8-9 weeks were given an initial vaccination course of a combination vaccine consisting of one dose of Feligen RCP (against feline rhinotracheitis virus, feline calicivirus and feline panleucopenia virus) with one dose of Leucogen.
Maltese: Fit-tieni studju, frieħ tal-età ta' 8 sa 9 ġimgħat ingħataw kors ta' tilqim inizjali ta' vaċċin ikkombinat li kien jikkonsisti minn doża waħda ta' Feligen RCP (kontra l-virus tar-rinotrakeite tal-qtates, il-kaliċivirus tal-qtates u l-virus tal-panlewkopenja tal-qtates) b'doża waħda ta' Leucogen.
English: Leucogen contains small amounts of a protein from the outer layer of the virus called ‘envelope p45 protein'.
Maltese: Leucogen fih ammonti żgħar ta' proteina mis-saff ta' barra tal-virus li tissejjaħ ‘proteina envelop p45'.
English: Leucogen is a vaccine.
Maltese: Leucogen huwa vaċċin.
English: Following the first booster vaccination protection lasts 3 years.
Maltese: Wara l-ewwel tilqima booster il-protezzjoni ddum 3 snin.
English: Leucogen also contains aluminium hydroxide gel and extract of Quillaja saponaria as adjuvants
Maltese: Leucogen fih ukoll ġell tal-idrossidu tal-aluminju u estratt ta' Quillaja saponaria bħala aġġuvanti
English: The most common side effects with Leucogen (which may affect up to 1 in 10 cats) are a moderate and short-lived local reaction (<2 cm) after the first injection which resolves without treatment within 3 to 4 weeks, raised body temperature (lasting 1 to 4 days), apathy (listlessness) and digestive disturbances.
Maltese: L-effetti sekondarji l-aktar komuni b'Leucogen (li jistgħu jaffettwaw sa qattus 1 minn kull 10) huma reazzjoni lokali moderata u temporanja (<2 cm) wara l-ewwel injezzjoni li tgħaddi mingħajr kura fi żmien 3 sa 4 ġimgħat, żieda fit-temperatura tal-ġisem (li ddum bejn jum u erbat ijiem), apatija (telqa) u disturbi diġestivi.
English: What are the risks associated with Leucogen?
Maltese: X'inhuma r-riskji assoċjati ma' Leucogen?
English: In one field study kittens aged 8 to 9 weeks were given an initial vaccination course of Leucogen with 2 injections 3 weeks apart and an annual booster injection 1 year later.
Maltese: Fi studju wieħed fuq il-post, frieħ tal-età ta' 8 sa 9 ġimgħat ingħataw kors ta' tilqim inizjali ta' Leucogen b'2 injezzjonijiet 3 ġimgħat minn xulxin u injezzjoni booster annwali sena wara.
English: A laboratory study in which cats were exposed to feline leukaemia virus confirmed that following the first annual booster vaccination cats were protected for a three year period against leukaemia.
Maltese: Studju fil-laboratorju li fih qtates kienu esposti għall-virus tal-lewkimja tal-qtates ikkonferma li wara l-ewwel tilqima booster annwali l-qtates kienu protetti għal perjodu ta' tliet snin kontra l-lewkimja.
English: Leucogen is a veterinary vaccine used in cats from eight weeks of age to protect them against feline leukaemia.
Maltese: Leucogen huwa vaċċin veterinarju li jintuża fil-qtates mill-età ta' tmien ġimgħat biex jipproteġihom kontra l-lewkimja tal-qtates.
English: How is Leucogen used?
Maltese: Kif jaħdem Leucogen?
English: Signs of the disease can include loss of appetite, weight loss, poor fur condition, fever, pale gums and diarrhoea; cats persistently infected with the virus may spread it to other cats.
Maltese: Is-sinjali tal-marda jistgħu jinkludu telf ta' aptit, telf fil-piż, kundizzjoni ħażina tal-pil, deni, ħanek bajdani u dijarea; il-qtates li jkunu infettati b'mod persistenti bil-virus jistgħu jgħadduh lil qtates oħra.
English: Some 64% of cats still had FeLV antibodies before the annual booster, and 100% of cats had FeLV antibodies after the booster.
Maltese: Xi 64 % mill-qtates xorta kellhom antikorpi tal-FeLV qabel il-booster annwali, u 100 % tal-qtates kellhom antikorpi tal-FeLV wara l-booster.
English: In the future, the immune system will be able to produce antibodies more quickly when it is exposed to FeLV, which will help to protect against the disease caused by the virus.
Maltese: Fil-futur, is-sistema immunitarja tkun kapaċi tipproduċi antikorpi aktar malajr meta tiġi esposta għall-FeLV, u dan se jgħin biex tipproteġi kontra l-marda kkawżata mill-virus.
English: Why is Leucogen authorised in the EU?
Maltese: Għalfejn Leucogen huwa awtorizzat fl-UE?
English: The FeLV protein used in the vaccine is not extracted from viruses but is made in a bacterium using ‘recombinant technology'.
Maltese: Il-proteina FeLV li tintuża fil-vaċċin ma tiġix estratta mill-virusis iżda ssir f'batterju bl-użu ta' ‘teknoloġija rikombinanti'.
English: The vaccine is used to prevent the disease signs and persistent viraemia (the presence of FeLV in the blood).
Maltese: Il-vaċċin jintuża biex jipprevjeni s-sinjali tal-marda u viremija persistenti (il-preżenza ta' FeLV fid-demm).
English: For the full list of restrictions and all side effects reported with Leucogen, see the package leaflet.
Maltese: Għal-lista sħiħa tar-restrizzjonijiet u tal-effetti sekondarji kollha rrappurtati b'Leucogen, ara l-fuljett ta' tagħrif.
English: 1 pre-filled pen
Maltese: Il-pakkett li jmiss malprodott
English: No data available.
Maltese: M'hemmx dejta disponibbli.
English: QUALITATIVE AND QUANTITATIVE COMPOSITION Active substance:
Maltese: U KWANTITATTIVA Sustanza attiva :
English: PL: Polska VIRBAC Sp. z o.o.
Maltese: Polska VIRBAC Sp. z o.o. ul.
English: ATCvet code: QD07AC.
Maltese: QD07AC.
English: Pharmacotherapeutic group: Glucorticosteroids, dermatological preparations.
Maltese: Grupp farmako-terapewtiku: Glukokortikosterojdi, sustanzi dermatoloġiċi.
English: PHARMACEUTICAL FORM Cutaneous spray, solution.
Maltese: FORMA FARMAĊEWTIKA Sprej kutanju, likwidu.
English: Propylene glycol methyl ether.
Maltese: Eteru glikol metil propilin
English: This transformation is responsible for the potency of the therapeutic class.
Maltese: Din it-trasformazzjoni hi responsabbli għall-potenza tal-klassi terapewtika.
English: VIRBAC Danmark A/S Profilvej 1 6000 Kolding Danmark Tel: +45
Maltese: VIRBAC Danmark A/S Profilvej 1 6000
English: Avenue 2065 m LID
Maltese: 1ère avenue 2065 m LID
English: CZ: Česká republika VIRBAC
Maltese: Česká republika VIRBAC
English: 06516 Carros, France
Maltese: 06516 Carros Francuska
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports).>
Maltese: Il-frekwenza ta' reazzjonijiet avversi hija definita bl-użu tal-konvenzjoni li ġejja: - komuni ħafna (aktar minn wieħed minn kull 10 annimali kkurati juru reazzjoni(jiet) avversa/avversi) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal ikkurat) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal ikkurat) - rari (aktar minn wieħed iżda inqas minn 10 annimali f'10,000 annimal ikkurat) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal ikkurat, inklużi rapporti iżolati).>
English: METHOD AND ROUTE(S) OF ADMINISTRATION Cutaneous use.
Maltese: METODU U MOD(I) TA' AMMINISTRAZZJONI Għall-użu kutanju.
English: The frequency of adverse reactions is defined using the following convention: - very common (more than 1 in 10 animals treated displaying adverse reaction(s)) - common (more than 1 but less than 10 animals in 100 animals treated ) - uncommon (more than 1 but less than 10 animals in 1,000 animals treated) - rare (more than 1 but less than 10 animals in 10,000 animals treated ) - very rare (less than 1 animal in 10,000 animals treated, including isolated reports)
Maltese: Il-frekwenza ta' reazzjonijiet avversi hija definita bl-użu tal-konvenzjoni li ġejja: - komuni ħafna (aktar minn wieħed minn kull 10 annimali kkurati juru reazzjoni(jiet) avversa/avversi) - komuni (aktar minn wieħed iżda inqas minn 10 annimali f'100 annimal ikkurat) - mhux komuni (aktar minn wieħed iżda inqas minn10 annimali f'1,000 annimal ikkurat) - rari (aktar minn wieħed iżda inqas minn 10 annimali f'10,000 annimal ikkurat) - rari ħafna (inqas minn annimal wieħed f'10,000 annimal ikkurat, inklużi rapporti iżolati).
English: LT: Lietuva VIRBAC
Maltese: Lietuva VIRBAC
English: Carton box with a PET bottle of 31ml Carton box with a PET bottle of 76ml Carton box with a HDPE bottle of 31ml Carton box with a HDPE bottle of 76ml
Maltese: Kaxxa tal-kartun bi flixkun (PET) ta' 31 ml Kaxxa tal-kartun bi flixkun (PET) ta' 76 ml Kaxxa tal-kartun bi flixkun (HDPE) ta' 31 ml Kaxxa tal-kartun bi flixkun (HDPE) ta' 76 ml
English: MANUFACTURER OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
Maltese: MANIFATTUR TAS-SUSTANZA BIJOLOĠIKA ATTIVA U L-MANIFATTUR RESPONSABBLI
English: Tolerance studies using 3 and 5 times the recommended dosage for twice the recommended duration of treatment resulted in a reduced capacity for production of cortisol that is fully reversible within 7 to 9 weeks after the end of treatment.
Maltese: Studji ta' tolleranza li użaw 3 u 5 darbiet id-dożaġġ rakkomandat għal durazzjoni ta' trattament doppju irriżulta f'tnaqqis ta' kapaċità għal produzzjoni ta' kortisol li hu kompletament riversibbli fi żmien 7 sa 9 ġimgħat wara t-tmiem ta' trattament.
English: Box containing a polyethylene terephtalate (PET) or high density polyethylene (HDPE) bottle filled with 31 ml or 76 ml of solution, closed with an aluminium screw cap or a white plastic screw cap and a pump spray.
Maltese: Kaxxa li fiha flixkun polietilene tereftalat (PET) jew tal-polietilen ta' densità għolja (HDPE) mimli b'31 ml jew 76 ml ta' likwidu, magħluq b'għatu skrun tal-aluminju jew tapp bil-kamin tal-plastik abjad u pompa tal-isprej.
English: Hydrocortisone aceponate applications on the skin lesions provide rapid reduction of the skin redness, irritation and scratching while minimising the general effects.
Maltese: Applikazzjonijiet l-aċeponat idrokortison fuq il-feriti fil-ġilda jipprovdu nuqqas rapidu ta' ħmura filġilda, irritazzjoni u ħakk waqt it-tnaqqis tal-effetti ġenerali.
English: ROUTE(S) OF ADMINISTRATION Cutaneous use.
Maltese: MOD(I) TA' AMMINISTRAZZJONI Għall-użu kutanju.
English: INDICATIONS For symptomatic treatment of inflammatory and pruritic dermatoses in dogs.
Maltese: Għat-trattament sintomatiku ta' dermatożi infjammatorji u pruritiċi fi klieb.
English: QUANTITY OF THE ACTIVE SUBSTANCE(S) Hydrocortisone aceponate 0.584 mg/ml.
Maltese: TAS-SUSTANZA(I) ATTIVA(I) Aċeponat idrokortison 0.584 mg/ml
English: NAME OF THE VETERINARY MEDICINAL PRODUCT CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs Hydrocortisone aceponate
Maltese: VETERINARJU CORTAVANCE 0.584 mg/ml sprej likwidu kutanju għall-klieb.
English: In laboratory animals, hydrocortisone aceponate is eliminated the same way as hydrocortisone (other name for endogenous cortisol) through urine and faeces.
Maltese: Fl-annimali tal-laboratorju, l-aċeponat idrokortison jiġi eliminat bl-istess mod bħal idrokortison (isem ieħor għal kortisol endoġenu) vija urina u ħara.
English: MARKETING AUTHORISATION NUMBER(S) Carton box with a PET bottle of 76ml: EU/2/06/069/001
Maltese: TAL-AWTORIZZAZZJONI TAL-KUMMERĊ Kaxxa tal-kartun bi flixkun (PET) ta' 76 ml: EU/2/06/069/001 Kaxxa tal-kartun bi flixkun (HDPE) ta' 76 ml: EU/2/06/069/004 17.
English: STATEMENT OF ACTIVE SUBSTANCES Hydrocortisone aceponate 0.584 mg/ml
Maltese: Aċeponat idrokortison 0.584 mg/ml
English: Otherwise, use only according to the risk-benefit assessment and subject the dog to regular clinical evaluations.
Maltese: Inkella, uża biss skont il-valutazzjoni ta' riskju-benefiċċju u ssuġġetta l-kelb għal evalwazzjonijiet kliniċi regolari.
English: In 12 dogs suffering from atopic dermatitis, after topical application on the skin at the recommended therapeutic dosage for 28 to 70 consecutive days, no noticeable effect on the systemic cortisol level was observed.
Maltese: Fi 12-il kelb li jbatu minn dermatite atopika, wara applikazzjoni topikali fuq il-ġilda bid-doża rakkomandata terapewtika għal 28 sa 70 jum konsekuttiv, ma kienx hemm effett osservat fuq il-livell kortisol sistemiku.
English: The recommended dosage is 1.52 µg of hydrocortisone aceponate/cm2 of affected skin per day.
Maltese: Id-dożaġġ rakkomandat hu ta' 1.52 µg ta' aċeponat idrokortison/ċm2 tal-ġilda affettwata kuljum.
English: MARKETING AUTHORISATION NUMBER(S) Carton with a PET bottle of 31ml: EU/2/06/069/002
Maltese: TAL-AWTORIZZAZZJONI TAL-KUMMERĊ Kaxxa tal-kartun bi flixkun (PET) ta' 31 ml: EU/2/06/069/002 Kaxxa tal-kartun bi flixkun (HDPE) ta' 31 ml: EU/2/06/069/003 17.
English: PACKAGE LEAFLET CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs
Maltese: FIL-PAKKETT CORTAVANCE 0.584 mg/ml sprej likwidu kutanju għall-klieb.
English: IE: Ireland
Maltese: Ireland
English: Hydrocortisone aceponate 0.584 mg/ml For the full list of excipients, see section 6.1
Maltese: CORTAVANCE 0.584 mg/ml sprej likwidu kutanju għall-klieb.
English: NAME OF THE VETERINARY MEDICINAL PRODUCT CORTAVANCE 0.584 mg/ml cutaneous spray solution for dogs Hydrocortisone aceponate STATEMENT OF THE ACTIVE SUBSTANCE(S) AND OTHER INGREDIENT(S) Hydrocortisone aceponate 0.584 mg/ml.
Maltese: materjali oħra għar-rimi derivati mill-uzu ta' dan it-tip ta' prodott Kull prodott mediċinali veterinarju li ma ġiex użat jew materjali għar-rimi derivati minn dan it-tip ta' prodotti mediċinali veterinarji għandhom jintremew skont il-kondizzjonijiet lokali meħtieġa.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box with a bottle of 31 ml
Maltese: Kaxxa tal-kartun bi flixkun (PET) ta' 31 ml
English: In case of conditions requiring an extended treatment, the responsible veterinarian should subject the use of the product to the risk-benefit assessment by the responsible veterinarian.
Maltese: F'każ ta' kondizzjonijiet fejn trattament imtawwal hu meħtieġ, il-veterinarju responsabbli għandu jissoġġetta l-użu tal-prodott mediċinali veterinarju għal valutazzjoni ta' riskju-benefiċċju.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE Carton box with a bottle of 76 ml
Maltese: Kaxxa tal-kartun bi flixkun (HDPE) ta' 76 ml
English: VIRBAC 1ère avenue 2065 m LID 06516 Carros FRANCE
Maltese: VIRBAC 1ère avenue 2065 m L.I.D. 06516 Carros FRANCE
English: Av. Associação Comercial e Industrial de Gondomar, 330 - Zona Industrial da Portelinha
Maltese: Associação Comercial e Industrial de Gondomar, 330 - Zona Industrial da Portelinha
English: Pol. Industrial Alcobendas 28108 Alcobendas
Maltese: Industrial Alcobendas 28108 Alcobendas
English: Av. José Malhoa - Edifício Malhoa Plaza nº 2, pisoescritório 2.2
Maltese: José Malhoa - Edifício Malhoa Plaza nº 2, pisoescritório 2.2
English: Av. dos Bombeiros Voluntários, nº 146 - 1º, 2765-201 Estoril Portugal
Maltese: dos Bombeiros Voluntários, nº 146 - 1º, 2765-201 Estoril Portugal
English: BG - Bulgaria Tchaikapharma High Quality Medicines, 1, G.M.
Maltese: BG - Il-Bulgarija Tchaikapharma High Quality Medicines, 1, G.M.
English: DE - Germany KSK-Pharma Vertriebs AG Finkenstr.
Maltese: DE - Il-Ġermanja KSK-Pharma Vertriebs AG Finkenstr.
English: 1036 Budapest Hungary ( The company is the member of TEVA Group Teva Magyarország zRt,1134budapest, Róbert Károly krt.59))
Maltese: Hungary ( The company is the member of TEVA Group Teva Magyarország zRt,1134budapest, Róbert Károly krt.59))
English: BE - Belgium Mylan BVBA/SPRL Terhulpsesteenweg 6A 1560 Hoeilaart
Maltese: BE - Il-Belġju Mylan BVBA/SPRL Terhulpsesteenweg 6A 1560 Hoeilaart
English: Sanofi-Aventis Estonia OÜ Pärnu mnt 139E/2
Maltese: ET - L-Estonja Sanofi-Aventis Estonia OÜ Pärnu mnt 139E/2
English: TH. PETALA 41
Maltese: PETALA 41
English: Av. D. João II, 10 EsqºTorre Fernão de Magalhães 1998-025 Lisboa, Portugal
Maltese: D. João II, 10 EsqºTorre Fernão de Magalhães 1998-025 Lisboa, Portugal
English: FIDIA FARMACEUTICI SpA Via Ponte D/Fabbrica, 3/A
Maltese: SpA Via Ponte D/Fabbrica, 3/A
English: 2051 Biatorbágy Hungary
Maltese: 2051 Biatorbágy
English: SE - Sweden PLIVA Pharma Ltd, Vision House, Bedford Road,
Maltese: SE - L-Isvezja PLIVA Pharma Ltd, Vision House, Bedford Road,
English: Warner Chilcott France Immeuble "Le Jean Monnet" 11, Place des Vosges 92061 Paris La Défense Cedex
Maltese: Warner Chilcott France Immeuble "Le Jean Monnet" 11, Place des Vosges 92061 Paris La
English: Viale Shakespeare, 47 00144 Roma
Maltese: Viale Shakespeare, 47 00144
English: PHARMABILL Jægersborg Alle 213 2 th DK-2820 Gentofte Denmark
Maltese: PL - Il-Polonja PHARMABILL Jægersborg Alle 213 2 th DK-2820 Gentofte Denmark
English: LABORATORIOS COMBIX, S.L.San Rafael, 3.
Maltese: LABORATORIOS COMBIX, S.L.San Rafael, 3. Pol.
English: FIDIA FARMACEUTICI SpA Via Ponte Della Fabbrica, 3/A - 35031
Maltese: SpA Via Ponte Della Fabbrica, 3/A - 35031
English: PENSA PHARMA, S.A.U Jorge Comín (médico pediatra), 3 - bajos 46015 Valencia
Maltese: A.U Jorge Comín (médico pediatra), 3 - bajos 46015 Valencia
English: 11317 Tallinn ESTONIA
Maltese: 11317 Tallinn
English: 103, blvd Al. Stamboliyski Office Building Sofia Tower Level 8, 1303 Sofia Bulgaria
Maltese: Stamboliyski Office Building Sofia Tower Level 8, 1303 Sofia
English: MASTELLI Srl Via Bussana Vecchia, 32 18032 San Remo (IM)
Maltese: Srl Via Bussana Vecchia, 32 18032 San Remo (IM)
English: FARMACEUTICI CABER SpA Viale Città d' Europa, 681 00144 Roma
Maltese: FARMACEUTICI CABER SpA Viale Città d' Europa, 681 00144
English: MYLAN SAS 117, allée des Parcs 69800 Saint-Priest FRANCE
Maltese: SAS 117, allée des Parcs 69800 Saint-Priest FRANCE
English: LABORATORIES , Str. Av. Petre Creţu nr. 74, et. 1, ap. 2, sect.
Maltese: Petre Creţu nr. 74, et. 1, ap. 2, sect.
English: Meda, postboks 194, 1371 Asker Norawy
Maltese: NO - In-Norveġja Meda, postboks 194, 1371 Asker Norawy
English: LABORATORIOS ALACAN INDUSTRIAS QUIMICO FARMACEUTICAS, S.A.Sagitario, 14 03006 Alicante
Maltese: INDUSTRIAS QUIMICO FARMACEUTICAS, S.A.Sagitario, 14 03006 Alicante
English: NL - Netherlands Bayer B.V. Energieweg 1
Maltese: NL - L-Olanda Bayer B.V. Energieweg 1
English: Al. Jana Pawła II 23
Maltese: Jana Pawła II 23
English: DE - Germany Basics GmbH Hemmelrather Weg 201
Maltese: DE - Il-Ġermanja Basics GmbH Hemmelrather Weg 201
English: TEVA Sweden AB, Järnvägsgatan 11, BOX
Maltese: FI - Il-Finlandja TEVA Sweden AB, Järnvägsgatan 11, BOX
English: SE - Sweden Hexal A/S Kanalholmen 8-12
Maltese: SE - L-Isvezja Hexal A/S Kanalholmen 8-12
English: Al. Jana Pawła II 80
Maltese: Jana Pawła II 80
English: SK - Slovakia medac GmbH Theaterstraße 6
Maltese: SK - ls-Slovakkja medac GmbH Theaterstraße 6
English: SE - Sweden HELP S.A. Pharmaceuticals 10, Valaoritou Str.
Maltese: SE - L-Isvezja HELP S.A. Pharmaceuticals 10, Valaoritou Str.
English: EVANGELOS KALOFOLIAS & CO IAPHARM
Maltese: EVANGELOS KALOFOLIAS & CO
English: BE - Belgium Procter & Gamble Pharmaceuticals SA.NV.
Maltese: BE - Il-Belġju Procter & Gamble Pharmaceuticals SA.NV.
English: NL - Netherlands Centrafarm Services B.V. Nieuwe Donk 9
Maltese: Centrafarm Services B.V. Nieuwe Donk 9
English: BE - Belgium Bayer SA.NV.
Maltese: BE - Il-Belġju Bayer SA.NV.
English: GEDEON RICHTER ROMÂNIA S.A. , România
Maltese: RO - Ir-Rumanija GEDEON RICHTER ROMÂNIA S.A. , România
English: ROTTAPHARM SpA Via Galleria Unione,5 20122 Milano (MI)
Maltese: SpA Via Galleria Unione,5 20122 Milano (MI)
English: Novartis s.r.o., U nákladového nádraží 3265/10, 130 00 PrahaStrašnice (Nagano III.
Maltese: Novartis s.r.o., U nákladového nádraží 3265/10, 130 00 PrahaStrašnice (Nagano III.), Czech Republic
English: HU - Hungary Novartis Hungária Kft. Pharma részlege
Maltese: HU - L-Ungerija Novartis Hungária Kft. Pharma részlege
English: FI - Finland sanofi-Aventis Oy, Huopalahdentie 24, PL 22, 00350 Helsinki, Finland
Maltese: FI - Il-Finlandja sanofi-Aventis Oy, Huopalahdentie 24, PL 22, 00350 Helsinki, Finland
English: MERCK SHARP & DOHME ROMÂNIA S.R.L.Bucharest Business ParkŞos.
Maltese: RO - Ir-Rumanija MERCK SHARP & DOHME ROMÂNIA S.R.L.Bucharest Business ParkŞos.
English: SE - Sweden 1A Farma A/S Herstedøstervej 27-29
Maltese: SE - L-Isvezja 1A Farma A/S Herstedøstervej 27-29
English: Viale Giorgio Ribotta, 11 00144 Roma
Maltese: Viale Giorgio Ribotta, 11 00144
English: DK - Denmark Bayer AB, Postbox 606, Gustav III:s Boulevard 56, SE-16926 Solna
Maltese: Bayer AB, Postbox 606, Gustav III:s Boulevard 56, SE-16926 Solna
English: ABC FARMACEUTICI SpA Corso Vittorio Emanuele II,
Maltese: SpA Corso Vittorio Emanuele II,
English: RO - Romania BAYER SCHERING PHARMA OY,
Maltese: RO - Ir-Rumanija BAYER SCHERING PHARMA OY,
English: SE - Sweden Meda AB 170 09 Solna
Maltese: SE - L-Isvezja Meda AB 170 09 Solna
English: STADA Hemofarm SRL Zugrav Nedelcu nr.3, Timişoara, Romania
Maltese: RO - Ir-Rumanija STADA Hemofarm SRL Zugrav Nedelcu nr.3, Timişoara, Romania
English: HOSPIRA ITALIA Srl Via Orazio, 20/22 80122 Napoli
Maltese: Srl Via Orazio, 20/22 80122 Napoli
English: Spafield, Cork Road, Cashel, Co. Tipperary
Maltese: Spafield, Cork Road, Cashel, Co.
English: Edifício Atlas II, Av. José Gomes Ferreira, N.º 11 - 3º, Sala 31,
Maltese: José Gomes Ferreira, N.º 11 - 3º, Sala 31,
English: Disodium clodronate tetrahydrate tablet
Maltese: Disodium clodronate tetrahydrate
English: DOC GENERICI Srl Via Manuzio, 7 - 20124 Milano
Maltese: DOC GENERICI Srl Via Manuzio, 7 - 20124
English: NOVARTIS FARMA SpA Largo Umberto Boccioni, 2 21040 Origgio (VA)
Maltese: NOVARTIS FARMA SpA Largo Umberto Boccioni, 2 21040
English: Bayer Schering Pharma AG Berlin, D-13342, Germany
Maltese: PL - Il-Polonja Bayer Schering Pharma AG Berlin, D-13342, Germany
English: Str. Av. Petre Creţu, nr.74, Sector 1, Bucureşti, Romania
Maltese: Petre Creţu, nr.74, Sector 1, Bucureşti, Romania
English: Pelplinska Str.
Maltese: Pelplińska st.
English: ABIOGEN PHARMA SpA Via Meucci, 36 - 56014 Ospedaletto (PI)
Maltese: ABIOGEN PHARMA SpA Via Meucci, 36 - 56014
English: Kemofarmacija d.d., cesta na Brdo 100, SI-1000
Maltese: SI - Is-Slovenja Kemofarmacija d.d., cesta na Brdo 100, SI-1000
English: DK - Denmark Helm AG, Nordkanalstrasse 28D, DE-20097 Hamburg, Germany
Maltese: Helm AG, Nordkanalstrasse 28D, DE-20097 Hamburg, Germany
English: NL - Netherlands All-gen Pharmaceuticals & Generics B.V.
Maltese: NL - L-Olanda All-gen Pharmaceuticals & Generics B.V.
English: Ranbaxy (Poland) Sp. z o.o.
Maltese: PL - Il-Polonja Ranbaxy (Poland) Sp. z o.o.
English: BE - Belgium TEVA Pharma Belgium N.V, Laarstraat 16,
Maltese: BE - Il-Belġju TEVA Pharma Belgium N.V, Laarstraat 16,
English: LABORATORI ALTER Srl Via Lomellina, 39 - 20124 Milano
Maltese: LABORATORI ALTER Srl Via Lomellina, 39 - 20124
English: HU - Hungary Medac GmbH Fehlandstrasse 3.
Maltese: HU - L-Ungerija Medac GmbH Fehlandstrasse 3.